PlatiNUM Medical Products

Brief Review of PlatiNUMís Medical Products and the Additional Funding
     Chief Investment Officer Westwood Ventures Irvine, California Prepared by Andrew

S. McAlister, CEO, Co-Founder Jason J. Smith, Senior Vice President, Co-Founder

December 6, 1999 TO: Mr. Greg Krel, Chief Investment Officer FROM: Andrew S. ,

Chief Executive Officer, Co-Founder Jason J. , Senior Vice President, Co-Founder

DATE: December 6, 1999 SUBJECT: Report on purpose of additional funding required
for future development of PlatiNUM Medical, Inc. This is the report on the
latest cardiovascular medical device that you requested on November 17, 1999.

This report discusses in explicit detail how we came to develop such an
effective device. The research and study methods, which were used, will be
introduced. We met with Doctors and patients in order to get accurate details
from both parties. These surveys were conducted in both the United States and in
several European Nations. As you can see, we have studied all angles, and have
developed a product superior to our competitors. Our device, the "PlatiNUM

Device" offers the best in medical technology. PlatiNUMís development
involved taking the best of other procedures and rolling it into one
multipurpose device. While eliminating the bad possibilities, which could occur
with other methods. Thank you for taking the time to read our proposal and
allowing PlatiNUM the chance to further benefit the world with safer, more
effective medical technology. On behalf of PlatiNUM Medical, Inc. and all of our
staff we are confident that this report will convince you to make the right
choice, and help put an end to the suffering of the millions of people with
heart disease. SUMMARY PlatiNUM Medical, Inc. was founded in 1995 and is located
in Irvine, California, centrally located in one of the leading medical device
development areas in the country. Our company is the leader in the development
of a new type of medical device for treating cardiovascular disease, also known
as heart disease. Despite on going efforts to combat this disease, no other
promising instruments have been introduced. The need still remains for a device
that can easily and safely remove dangerous tissues found in the arteries and
other problems associated with the heart. Through the past four years PlatiNUM
has conducted research in the U.S. as well as Europe. Surveys and interviews
were held with leading cardiovascular physicians to determine the best features
for the device. When this process was completed, we then took the next step,
which involved patient surveys and gathered input on what they thought was
needed. Although our research and data collecting will never end, the past four
years has given us the specifications, which must be met in the product that we
developed. Our research has led to the following: (1) A device, which eliminates
all possible complications, associated with heart disease today. (2) Something
that would not be as dangerous and risky as By-pass surgery. (3) A device which
is simple to use and requires no additional training. (4) Finally, a device
which is affordable, and efficient. PlatiNUM has developed a device that meets
and exceeds all of these strict standards. The PlatiNUM device with our patented

"Omni Cutter" does the trick. Hopefully, in the near future the citizens of
the world who suffer from heart disease will be fortunate to have this device
available. Physician Comments about the PlatiNUM device: "Best device ever for
treating Heart Disease" Thomas Ischeinger, MD "Best device ever for Failed

Bypass" David Cox, MD "Incredibly easy to set up and use...... adoption will

DISEASE AND COMPLICATIONS Introduction Heart problems are a way of life for many

Americans throughout the nation. Whether it is heredity, our diets, or some
other cause. Heart disease and related problems kill 10 million Americans
annually with numbers on the rise. With these skyrocketing numbers, it shows
that something needs to be done about this horrible condition. Fatality rates
due to heart disease need to come down, and the millions of Americans who suffer
from these problems deserve to lead happier, healthier lives. The methods used
today are drastically failing and do not have promising success rates. Highly
respected medical physicians such as Dr. Thomas Ischeinger, Dr. David Cox, and

Dr. Gregg Stone will tell you the same. This is why PlatiNUM felt the need to
develop a new, safer device. A device that will drastically bring down the
fatality rates involved with heart disease. Purpose for the Research: The
purpose for our research was to develop a device, which rose above the standards
of all the others. One that eliminated all of the negative side effects of the
competitors, and incorporated many of the good features of the others. Not only
the helpful aspects of the others, but many new aspects as well. Most
importantly above all else is the continued research to get FDA approval in
order for this device to be used in the United States. Answers were sought to
the following questions. 1. What are the current problems associated with heart
disease treatment today? 2. What should our device be designed to do? 3. What
legal issues are raised regarding the use of this device? 4. Why would this
device be such a success? Methods and Procedures Used: Most of the information
and data collected was gathered through the countless surveys and interviews
conducted in both Europe and in the U.S. Our staff visited numerous, highly
specialized medical officials, each one at the top of their field. We asked them
their opinions, and what they would like to see in a new product. We then hit
the books, researching the leading causes in heart disease treatment failures,
and tried to determine that went wrong and why. 1 2 Problems Which Frequently

Occur: Bypass surgery, which is the surgical procedure most historically,
conducted is extremely risky. 20 percent fail within the first year and more
than 50 percent within 10 years. Because of the high risk of the surgery many go
untreated. Another problem involves the use of Stents. Stents are small tube
like instruments, which are designed to maintain a normal bloodstream. Well,

20-25 percent of these cases fail within the first 6 months. As small as it is
these are primarily the only treatments currently being used and the problems
which go along with them. Benefits of having the PlatiNum device: Our device
eliminates all the problems I just mentioned. The PlatiNum device surpasses all
competition and all of those medical professionals who use it, will love it. The

PlatiNum device removes dangerous clots in the arteries caused from massive
tissue blocks or by the procedures I mentioned before. With PlatiNumís
patented "Omni cutter" we can now treat diseased coronary arteries. By
positioning this cutter at the tip of whatís called a catheter, a powerful
force is created bringing dangerous, occlusive tissue into the catheter. This
junk is than removed by vacuum from the blood vessel. No major surgery needed
and completely safe. So far from the news in Europe all is going well. Another
benefit is the way the device is packaged. It comes is a simple, disposable
unit. For doctors this is a tremendous convenience. This device comes fully
assembled and is easy to use. I believe this device pretty much sells itself,
all we need is to get this wonderful product available in the U.S. Legal

Considerations in Marketing: Many considerations for the use of a medical device
must be met to ensure product safety. Governmental agencies were established to
set the standards and guidelines for the quality and use of medical devices in
humans. As with the United States and the FDA or Food and Drug Administration,

Europe has its agency known as CE Mark, a review board made up of doctors and
insurance representatives which meet and review the safety and applications of
such medical devices and procedures. Approval by CE Mark was made earlier this
year, with FDA approval just around the corner. As with all approval agencies,
the burden of safety falls on the product. With the impressive safety records

PlatiNUM has established, we see no reason for postponement of the FDA approval
next fall. 3 Market Potential: Summary: This diagram illustrates the market
potential, which can be reached by the PlatiNUM device within the next 2-3
years. As you can see, there is enormous market potential for PlatiNUM Medical
to grow into in the future years. 4 Forecast for PlatiNUM over the next 2 years:

Summary: This graph illustrates the profits and revenues forecasted for the next

2 years at PlatiNUM. As you can see in 1998 the company was a small purely
involved in its research and development phase. In 1999, PlatiNUM began to
expand, introducing a clean room facility for product assembly, which can later
be used for manufacturing. In late 1999 CE Mark approval was granted, and

PlatiNUM began gearing up for European exporting. By early 2000, the first major
profits will show from the European market. By late 2000, FDA approval should be
granted, and PlatiNUMís facilities will gear up for major production of its
device for use in the American market, revenues will exceed 10 million dollars
and the company will begin to liquidate debt and show profits. By 2002, PlatiNUM
will be common practice in nearly all heart disease cases; we will have
revolutionized the medical industry.


EndiCOR Medical, Inc. Newsletter, Volume 6(15 November 1999) Responding to

Issues of Interventional Cardiology with the X-Sizer. David D. Gutterman, MD.

Professor of Cardiovascular Medicine, Medical College of Wisconsin,

Cardiovascular Research Center (12 November 1999) Heart Disease Can Be a Silent

Killer [On-Line] Available
[1999 November 29] National Institutes of Health (12 July, 1999) Heart Failure

Treatments [On-Line] Available
[1999 November 29] Karen A. Matthews, Ph.D., University of Pittsburgh School of

Medicine (September 18, 1998) Suppressed Anger Increases Heart Disease in Both

Men and Women [On-Line] Available
[1999 November 27], Heart Disease [On-Line] Available
[1999 November 27] World Medical Manufacturing Corp. Talent Stent-Graft System
[On-Line] Available [1999

November 28] FDA / Center for Food Safety & Applied Nutrition. Biotechnology
[On-Line] Available [1999 November

28] Cardiothoracic Surgery of Savannah. Advances in Open Heart Surgery (February

14,1999) [On-Line] Available [1999 November 28]